Erin J Aiello Bowles

Summary

Affiliation: Group Health Cooperative
Country: USA

Publications

  1. pmc Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer
    Erin J Aiello Bowles
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    J Oncol Pract 8:e149-57. 2012
  2. pmc Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study
    Erin J Aiello Bowles
    Group Health Research Institute, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    J Natl Cancer Inst 104:1293-305. 2012
  3. pmc Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database
    Erin J Aiello Bowles
    Group Health Research Institute, Group Health Cooperative, Seattle, WA 98101, USA
    BMC Cancer 12:136. 2012
  4. pmc Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension
    Erin J Aiello Bowles
    Group Health Research Institute, Group Health Cooperative, Seattle, Washington 98101, USA
    J Womens Health (Larchmt) 19:1467-74. 2010
  5. pmc Radiologists' attitudes and use of mammography audit reports
    Joann G Elmore
    Division of General Internal Medicine, 325 Ninth Avenue, University of Washington, Seattle, WA 98104, USA
    Acad Radiol 17:752-60. 2010
  6. doi request reprint Mammographic breast density and serum phytoestrogen levels
    Sarah J Lowry
    Group Health Research Institute, Seattle, Washington 98101, USA
    Nutr Cancer 64:783-9. 2012
  7. pmc Predictors of breast density change after hormone therapy cessation: results from a randomized trial
    Sarah J Lowry
    Group Health Cooperative, Group Health Research Institute, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 20:2309-12. 2011
  8. pmc Short-term hormone therapy suspension and mammography recall: a randomized trial
    Diana S M Buist
    Group Health Center for Health Studies, University of Washington, and Group Health Permanente, 125 16th Avenue East, Seattle, WA 98112, USA
    Ann Intern Med 150:752-65. 2009
  9. doi request reprint Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer
    Larry A Allen
    Section of Advanced Heart Failure and Transplantation, Division of Cardiology, University of Colorado Anschutz Medical Center, Aurora, CO Department of Population Sciences, Henry Ford Hospital and Health System, Detroit, MI Department of Epidemiology, Boston University School of Public Health, Boston, MA Group Health Research Institute, Group Health Cooperative, Seattle, WA Division of Research, Kaiser Permanente Northern California, Oakland, CA Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School Department of Medicine, Harvard Vanguard Medical Associates, Boston, MA Center for Health Research Southeast, Kaiser Permanente Georgia, Atlanta, GA Marshfield Clinic Research Foundation, Marshfield Clinic, Marshfield Department of Hematology Oncology, Weston, WI Institute for Health Research, Kaiser Permanente Colorado, Denver, CO
    Med Care 52:e30-8. 2014
  10. pmc Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States
    Mellissa Yong
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 19:537-46. 2010

Detail Information

Publications17

  1. pmc Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer
    Erin J Aiello Bowles
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    J Oncol Pract 8:e149-57. 2012
    ..We conducted a larger self-report evaluation of endocrine therapy discontinuation associated with patient characteristics and therapy-related adverse effects...
  2. pmc Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study
    Erin J Aiello Bowles
    Group Health Research Institute, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    J Natl Cancer Inst 104:1293-305. 2012
    ..We estimated real-world adjuvant anthracycline and trastuzumab use and their associations with incident HF/CM...
  3. pmc Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database
    Erin J Aiello Bowles
    Group Health Research Institute, Group Health Cooperative, Seattle, WA 98101, USA
    BMC Cancer 12:136. 2012
    ..This paper describes our study protocol, data collection methods, and summarizes the strengths and limitations of these data...
  4. pmc Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension
    Erin J Aiello Bowles
    Group Health Research Institute, Group Health Cooperative, Seattle, Washington 98101, USA
    J Womens Health (Larchmt) 19:1467-74. 2010
    ..We hypothesized that women with dense breasts might have lower tolerance for short-term HT suspension than do women with fatty breasts...
  5. pmc Radiologists' attitudes and use of mammography audit reports
    Joann G Elmore
    Division of General Internal Medicine, 325 Ninth Avenue, University of Washington, Seattle, WA 98104, USA
    Acad Radiol 17:752-60. 2010
    ..The objectives of our study were to assess the content and style of audits and examine use of, attitudes toward, and perceptions of the value that radiologists' have regarding mandated medical audits...
  6. doi request reprint Mammographic breast density and serum phytoestrogen levels
    Sarah J Lowry
    Group Health Research Institute, Seattle, Washington 98101, USA
    Nutr Cancer 64:783-9. 2012
    ..Additional studies are needed to determine effects of higher levels, particularly given patterns of increasing phytoestrogen intake...
  7. pmc Predictors of breast density change after hormone therapy cessation: results from a randomized trial
    Sarah J Lowry
    Group Health Cooperative, Group Health Research Institute, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 20:2309-12. 2011
    ..We investigated whether we could identify characteristics of women who were most likely to experience a decrease in MD due to hormone therapy cessation...
  8. pmc Short-term hormone therapy suspension and mammography recall: a randomized trial
    Diana S M Buist
    Group Health Center for Health Studies, University of Washington, and Group Health Permanente, 125 16th Avenue East, Seattle, WA 98112, USA
    Ann Intern Med 150:752-65. 2009
    ..Hormone therapy increases breast density, and abnormal screening mammograms are more common among women with denser breasts and among women using hormone therapy...
  9. doi request reprint Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer
    Larry A Allen
    Section of Advanced Heart Failure and Transplantation, Division of Cardiology, University of Colorado Anschutz Medical Center, Aurora, CO Department of Population Sciences, Henry Ford Hospital and Health System, Detroit, MI Department of Epidemiology, Boston University School of Public Health, Boston, MA Group Health Research Institute, Group Health Cooperative, Seattle, WA Division of Research, Kaiser Permanente Northern California, Oakland, CA Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School Department of Medicine, Harvard Vanguard Medical Associates, Boston, MA Center for Health Research Southeast, Kaiser Permanente Georgia, Atlanta, GA Marshfield Clinic Research Foundation, Marshfield Clinic, Marshfield Department of Hematology Oncology, Weston, WI Institute for Health Research, Kaiser Permanente Colorado, Denver, CO
    Med Care 52:e30-8. 2014
    ..The ability to accurately identify cardiotoxicity from administrative data would enhance safety information...
  10. pmc Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States
    Mellissa Yong
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 19:537-46. 2010
    ..We assessed relationships between functional polymorphisms in the UGT and SULT genes and breast density in premenopausal women...
  11. pmc Timing of follow-up after abnormal screening and diagnostic mammograms
    Karen J Wernli
    Group Health Research Institute, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    Am J Manag Care 17:162-7. 2011
    ..To evaluate woman-level characteristics associated with timing of follow-up after abnormal mammograms in an integrated healthcare system with an active breast health program...
  12. pmc Decreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factors
    Andrea J Cook
    Biostatistics Unit, Group Health Research Institute, Seattle, WA 98101, USA
    J Clin Epidemiol 63:441-51. 2010
    ....
  13. pmc Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history
    Megan L Welsh
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    Breast Cancer Res Treat 114:549-58. 2009
    ..We provide population-based estimates of breast cancer risk and different tumor subtypes in relation to the degree, number, and age at diagnosis of affected relatives...
  14. pmc No effect of aspirin on mammographic density in a randomized controlled clinical trial
    Anne McTiernan
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 18:1524-30. 2009
    ....
  15. doi request reprint Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States
    Charlotte Atkinson
    Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Breast Cancer Res Treat 116:587-94. 2009
    ....
  16. pmc Accuracy and complexities of using automated clinical data for capturing chemotherapy administrations: implications for future research
    Erin J Aiello Bowles
    Group Health Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Med Care 47:1091-7. 2009
    ..However, chemotherapy data obtained from tumor registries may be incomplete, and abstracting chemotherapy directly from medical records can be expensive and time consuming...
  17. pmc Best ways to provide feedback to radiologists on mammography performance
    Erin J Aiello Bowles
    Group Health Center for Health Studies, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    AJR Am J Roentgenol 193:157-64. 2009
    ..Since then, no studies have evaluated radiologists' perceptions of their audit reports, such as which performance measures are the most or least useful, or what the best formats are to present performance data...